Revenue Growth, Debt Conversion Boost Pressure BioSciences’ (PBIO) Outlook at Close of First Quarter
High-pressure lab equipment maker reports ninth consecutive quarter of revenue growth (Y/Y) About 92 percent of debenture debt converted to preferred stock, with aim of uplisting to national stock exchange Patented technologies continue to drive optimism for company’s products to enhance and improve scientific research Pressure BioSciences, Inc. (OTCQB: PBIO), the maker of a patented and powerful line of pressure-based scientific laboratory tools, celebrated corporate gains on May 15 with the announcement of first quarter revenue growth and debenture conversion. The first quarter of 2018 was the ninth consecutive quarter in which the company reported an increase in products and…